KRW 12000.0
(-11.37%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 14.51 Billion KRW | 49.49% |
2022 | 9.71 Billion KRW | -1.51% |
2021 | 9.85 Billion KRW | 4.61% |
2020 | 9.42 Billion KRW | 24.62% |
2019 | 7.56 Billion KRW | 1.44% |
2018 | 7.45 Billion KRW | -0.73% |
2017 | 7.5 Billion KRW | 14.36% |
2016 | 6.56 Billion KRW | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 14.31 Billion KRW | -1.2% |
2024 Q1 | 14.49 Billion KRW | -0.18% |
2023 Q1 | 11.1 Billion KRW | 14.35% |
2023 Q4 | 14.51 Billion KRW | 2.22% |
2023 Q3 | 14.2 Billion KRW | 16.78% |
2023 Q2 | 12.16 Billion KRW | 9.52% |
2023 FY | 14.51 Billion KRW | 49.49% |
2022 Q2 | 9.11 Billion KRW | -4.01% |
2022 Q1 | 9.49 Billion KRW | -3.68% |
2022 Q3 | 9.13 Billion KRW | 0.22% |
2022 Q4 | 9.71 Billion KRW | 6.3% |
2021 Q4 | 9.85 Billion KRW | 7.38% |
2021 Q3 | 9.18 Billion KRW | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
HLB Co., Ltd. | 11.42 Billion KRW | -27.101% |
iNtRON Biotechnology, Inc. | 1.01 Billion KRW | -1335.747% |
BINEX Co., Ltd. | 28.26 Billion KRW | 48.633% |
Bioneer Corporation | 41.35 Billion KRW | 64.896% |
Anterogen.Co.,Ltd. | 1.91 Billion KRW | -659.846% |
CrystalGenomics, Inc. | 1.55 Billion USD | -833.688% |
Helixmith Co., Ltd | 914.11 Million KRW | -1488.084% |
Chabiotech Co.,Ltd. | 34.11 Billion KRW | 57.449% |
Medy-Tox Inc. | 59.61 Billion KRW | 75.65% |
Peptron, Inc. | 172.18 Million KRW | -8330.873% |
Amicogen, Inc. | 46.83 Billion KRW | 69.006% |
Genexine, Inc. | 3.8 Billion KRW | -281.328% |
HLB Therapeutics Co.,Ltd. | 5.33 Billion KRW | -172.065% |
LegoChem Biosciences, Inc. | 196.83 Million KRW | -7275.184% |
ALTEOGEN Inc. | 1.06 Billion KRW | -1258.803% |
PharmaResearch Co., Ltd. | 50.23 Billion KRW | 71.101% |
SillaJen, Inc. | 1.21 Billion KRW | -1097.147% |
JETEMA, Co., Ltd. | 12.74 Billion KRW | -13.939% |
OliX Pharmaceuticals,Inc | 468.4 Million KRW | -2999.191% |
Genomictree Inc. | 496.53 Million KRW | -2823.661% |
MedPacto, Inc. | 620.00 KRW | -2341435016.452% |
D&D Pharmatech | 3.45 Billion KRW | -320.753% |
EASY BIO,Inc. | 25.93 Billion KRW | 44.034% |
GI Innovation, Inc. | - KRW | -Infinity% |